Product information

From Health Canada

Current status:

Marketed

Current status date:

2001-10-01

Original market date: See footnote 1

1999-01-21

Product name:

ACID CONCENTRATE 2151

DIN:

02239486 Electronic product monograph is not available

Company:

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Haemodialysis

Number of active ingredient(s):

6

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

40:34.00* See footnote6 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05ZA HEMODIALYTICS, CONCENTRATES

Active ingredient group (AIG) number:See footnote5

0617386406

List of active ingredient(s)
Active ingredient(s) Strength
ACETIC ACID 8.11 G / L
CALCIUM CHLORIDE 6.24 G / L
DEXTROSE 90 G / L
MAGNESIUM CHLORIDE 3.21 G / L
POTASSIUM CHLORIDE 3.35 G / L
SODIUM CHLORIDE 268 G / L
Version 4.0.2
Date modified: